| ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors JDE Philip L.S.M. Gordts, Ryan Nock, Ni-Huiping Son, Bastian Ramms,Irene Lew ... Journal of Clinical Investigation, 2016 | 229 | 2016 |
| Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes MAJ Kraakman MJ, Lee MKS, Al-Sharea A, Dragoljevic D, Barrett TJ, Montenont ... Journal of Clinical Investigation, 2017 | 188 | 2017 |
| Endothelial cell CD36 optimizes tissue fatty acid uptake NH Son, D Basu, D Samovski, TA Pietka, VS Peche, F Willecke, X Fang, ... The Journal of clinical investigation 128 (10), 4329-4342, 2018 | 184 | 2018 |
| Proteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity X Lei, F Shi, D Basu, A Huq, S Routhier, R Day, W Jin Journal of Biological Chemistry 286 (18), 15747-15756, 2011 | 152 | 2011 |
| Mechanism of increased LDL (low-density lipoprotein) and decreased triglycerides with SGLT2 (sodium-glucose cotransporter 2) inhibition D Basu, LA Huggins, D Scerbo, J Obunike, AE Mullick, PL Rothenberg, ... Arteriosclerosis, thrombosis, and vascular biology 38 (9), 2207-2216, 2018 | 129 | 2018 |
| Regulation of lipoprotein lipase-mediated lipolysis of triglycerides D Basu, IJ Goldberg Current opinion in lipidology 31 (3), 154-160, 2020 | 73 | 2020 |
| Determination of lipoprotein lipase activity using a novel fluorescent lipase assay [S] D Basu, J Manjur, W Jin Journal of lipid research 52 (4), 826-832, 2011 | 71 | 2011 |
| Endothelial cell receptors in tissue lipid uptake and metabolism NA Abumrad, AG Cabodevilla, D Samovski, T Pietka, D Basu, IJ Goldberg Circulation research 128 (3), 433-450, 2021 | 66 | 2021 |
| A dual apolipoprotein C-II mimetic–apolipoprotein C-III antagonist peptide lowers plasma triglycerides A Wolska, L Lo, DO Sviridov, M Pourmousa, M Pryor, SS Ghosh, R Kakkar, ... Science translational medicine 12 (528), eaaw7905, 2020 | 64 | 2020 |
| Novel reversible model of atherosclerosis and regression using oligonucleotide regulation of the LDL receptor D Basu, Y Hu, LA Huggins, AE Mullick, MJ Graham, T Wietecha, ... Circulation research 122 (4), 560-567, 2018 | 51 | 2018 |
| Hypertriglyceridemia and Atherosclerosis: Using Human Research to Guide Mechanistic Studies in Animal Models DBKE Bornfeldt Frontiers in Endocrinology, 2020 | 35 | 2020 |
| Hepatic overexpression of the prodomain of furin lessens progression of atherosclerosis and reduces vascular remodeling in response to injury X Lei, D Basu, Z Li, M Zhang, RD Rudic, XC Jiang, W Jin Atherosclerosis 236 (1), 121-130, 2014 | 20 | 2014 |
| Atherosclerosis regression and cholesterol efflux in hypertriglyceridemic mice T Josefs, D Basu, T Vaisar, B Arets, JE Kanter, LA Huggins, Y Hu, J Liu, ... Circulation research 128 (6), 690-705, 2021 | 17 | 2021 |
| Lipolytic enzymes and free fatty acids at the endothelial interface IJ Goldberg, AG Cabodevilla, D Samovski, V Cifarelli, D Basu, ... Atherosclerosis 329, 1-8, 2021 | 16 | 2021 |
| Angiopoietin-like 3: An important protein in regulating lipoprotein levels KH Burks, D Basu, IJ Goldberg, NO Stitziel Best Practice & Research Clinical Endocrinology & Metabolism 37 (3), 101688, 2023 | 14 | 2023 |
| Measurement of the phospholipase activity of endothelial lipase in mouse plasma D Basu, X Lei, J Josekutty, MM Hussain, W Jin Journal of Lipid Research 54 (1), 282-289, 2013 | 13 | 2013 |
| CREBH normalizes dyslipidemia and halts atherosclerosis in diabetes by decreasing circulating remnant lipoproteins M Shimizu-Albergine, D Basu, JE Kanter, F Kramer, V Kothari, S Barnhart, ... The Journal of Clinical Investigation 131 (22), 2021 | 12 | 2021 |
| Hepatic S1P deficiency lowers plasma cholesterol levels in apoB-containing lipoproteins when LDLR function is compromised D Basu, A Huq, J Iqbal, MM Hussain, XC Jiang, W Jin Nutrition & Metabolism 12, 1-14, 2015 | 8 | 2015 |
Adam E. MullickIonis Pharmaceuticals, Inc.Verified email at ionisph.com
